Skip Navigation



JAC Advance Access published online on September 1, 2003

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg390
© 2003 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
52/4/572    most recent
dkg390v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Tsuchiya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Tsuchiya, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 The British Society for Antimicrobial Chemotherapy

Brief report

A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa

Yang Li 1 , Takehiko Mima 1 , Yukiko Komori 1 , Yuji Morita 1 , Teruo Kuroda 1 , Tohru Mizushima 1 , and Tomofusa Tsuchiya 1 *

1 Department of Microbiology, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima, Okayama, 700-8530, Japan

* Corresponding author. E-mail: tsuchiya{at}pharm.okayama-u.ac.jp.

Received 30 April 2003 ; revised 19 June 2003 ; accepted 25 June 2003

Abstract

Objectives: Multidrug efflux pumps are thought to be involved in mediating multidrug resistance in Pseudomonas aeruginosa. Here we aim to characterize hitherto uncharacterized multidrug efflux pumps from P. aeruginosa.

Materials and methods: We isolated a mutant, YM442, which showed elevated resistance to several antimicrobial agents from P. aeruginosa YM44 lacking four major multidrug efflux pumps, MexAB, MexCD-OprJ, MexEF-OprN and MexXY. We cloned genes responsible for the resistance from chromosomal DNA of YM442 using YM44 as host.

Results: We designated the genes mexVW. Introduction of a recombinant plasmid pTAJ2 carrying the mexVW into YM44 cells conferred resistance to fluoroquinolones, tetracycline, chloramphenicol, erythromycin, ethidium bromide and acriflavine. Elevated ethidium bromide extrusion was observed with cells of YM442 and of YM44/pTAJ2. An outer membrane protein OprM was able to cooperate with MexVW. Elevated expression of the mexV gene was observed with YM442 compared with YM44.

Conclusions: MexV (membrane fusion protein)-MexW (RND-type membrane protein)-OprM is a tripartite multidrug efflux pump. It is suggested that other outer membrane component(s) could cooperate with MexVW.

Keywords: MexVW, multidrug efflux pump, RND-type, P. aeruginosa
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MicrobiologyHome page
T. Mima, N. Kohira, Y. Li, H. Sekiya, W. Ogawa, T. Kuroda, and T. Tsuchiya
Gene cloning and characteristics of the RND-type multidrug efflux pump MuxABC-OpmB possessing two RND components in Pseudomonas aeruginosa
Microbiology, November 1, 2009; 155(11): 3509 - 3517.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
P. D. Lister, D. J. Wolter, and N. D. Hanson
Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Clin. Microbiol. Rev., October 1, 2009; 22(4): 582 - 610.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
T. Strateva and D. Yordanov
Pseudomonas aeruginosa - a phenomenon of bacterial resistance
J. Med. Microbiol., September 1, 2009; 58(9): 1133 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. Vettoretti, P. Plesiat, C. Muller, F. El Garch, G. Phan, I. Attree, A. Ducruix, and C. Llanes
Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1987 - 1997.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Jeannot, S. Elsen, T. Kohler, I. Attree, C. van Delden, and P. Plesiat
Resistance and Virulence of Pseudomonas aeruginosa Clinical Strains Overproducing the MexCD-OprJ Efflux Pump
Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2455 - 2462.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
L. Zhang and T.-F. Mah
Involvement of a Novel Efflux System in Biofilm-Specific Resistance to Antibiotics
J. Bacteriol., July 1, 2008; 190(13): 4447 - 4452.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. M. Struble and R. T. Gill
Reverse Engineering Antibiotic Sensitivity in a Multidrug-Resistant Pseudomonas aeruginosa Isolate.
Antimicrob. Agents Chemother., July 1, 2006; 50(7): 2506 - 2515.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
L. Pumbwe, O. Ueda, F. Yoshimura, A. Chang, R. L. Smith, and H. M. Wexler
Bacteroides fragilis BmeABC efflux systems additively confer intrinsic antimicrobial resistance
J. Antimicrob. Chemother., July 1, 2006; 58(1): 37 - 46.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. Hocquet, P. Nordmann, F. El Garch, L. Cabanne, and P. Plesiat
Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa.
Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1347 - 1351.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. A. Alyaseen, K. E. Piper, M. S. Rouse, J. M. Steckelberg, and R. Patel
Selection of Cross-Resistance following Exposure of Pseudomonas aeruginosa Clinical Isolates to Ciprofloxacin or Cefepime
Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2543 - 2545.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
M. L. Sobel, S. Neshat, and K. Poole
Mutations in PA2491 (mexS) Promote MexT-Dependent mexEF-oprN Expression and Multidrug Resistance in a Clinical Strain of Pseudomonas aeruginosa
J. Bacteriol., February 15, 2005; 187(4): 1246 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. Kriengkauykiat, E. Porter, O. Lomovskaya, and A. Wong-Beringer
Use of an Efflux Pump Inhibitor To Determine the Prevalence of Efflux Pump-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa
Antimicrob. Agents Chemother., February 1, 2005; 49(2): 565 - 570.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
D. Nehme, X.-Z. Li, R. Elliot, and K. Poole
Assembly of the MexAB-OprM Multidrug Efflux System of Pseudomonas aeruginosa: Identification and Characterization of Mutations in mexA Compromising MexA Multimerization and Interaction with MexB
J. Bacteriol., May 15, 2004; 186(10): 2973 - 2983.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
J. K. Middlemiss and K. Poole
Differential Impact of MexB Mutations on Substrate Selectivity of the MexAB-OprM Multidrug Efflux Pump of Pseudomonas aeruginosa
J. Bacteriol., March 1, 2004; 186(5): 1258 - 1269.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
G.-X. He, T. Kuroda, T. Mima, Y. Morita, T. Mizushima, and T. Tsuchiya
An H+-Coupled Multidrug Efflux Pump, PmpM, a Member of the MATE Family of Transporters, from Pseudomonas aeruginosa
J. Bacteriol., January 1, 2004; 186(1): 262 - 265.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.